Work

Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans

Year: 2018

Type: article

Source: American Journal Of Pathology

DOI: 10.1016/j.ajpath.2017.12.017

Authors: Shanshan Zhang, Jingxiao Wang, Haichuan Wang, Lingling Fan, Biao Fan, Billy Zeng, Junyan Tao, Xiaolei Li, Li Che, Antonio Cigliano, Silvia Ribback, Frank Dombrowski, Bin Chen, Wenming Cong, Lixin Wei, Diego F. Calvisi, Xin Chen

Institutions: Second Military Medical University, University of California, San Francisco, Eastern Hepatobiliary Surgery Hospital, Beijing University of Chinese Medicine, Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Peking University Cancer Hospital, Gastroenterology Hospital "Saverio de Bellis", Universität Greifswald

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Johns Hopkins University, China Scholarship Council, National Institutes of Health, University of California, San Diego, University of California, San Francisco, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences, Liver Center, University of California, San Francisco

Awards: Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma, G1978185739, G208418196, Signaling cascades in cholangiocarcinoma development, Integrating transcriptomic, proteomic and pharmacogenomic data to inform individualized therapy in cancers, Molecular Genetics of Liver Cancers, UCSF Liver Center

OpenAlex ID: W2786994407

FWCI: 3.046

Cites: 71

Cited by: 36

Related to: 10